SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-047253
Filing Date
2021-09-08
Accepted
2021-09-08 07:05:24
Documents
13
Period of Report
2021-09-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fnch-8k_20210908.htm   iXBRL 8-K 51783
2 EX-99.1 fnch-ex991_6.htm EX-99.1 15458
  Complete submission text file 0001564590-21-047253.txt   208381

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fnch-20210908.xsd EX-101.SCH 5705
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fnch-20210908_lab.xml EX-101.LAB 20068
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fnch-20210908_pre.xml EX-101.PRE 11949
6 EXTRACTED XBRL INSTANCE DOCUMENT fnch-8k_20210908_htm.xml XML 3820
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Filer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40227 | Film No.: 211240630
SIC: 2836 Biological Products, (No Diagnostic Substances)